Ragatz William 4
4 · Viela Bio, Inc. · Filed Jan 29, 2020
Insider Transaction Report
Form 4
Ragatz William
VP, Head of Commercial
Transactions
- Exercise/Conversion
Common Stock
2020-01-27$5.22/sh+16,250$84,825→ 16,250 total - Exercise/Conversion
Stock Option (right to buy)
2020-01-27−16,250→ 48,750 totalExercise: $5.22Exp: 2029-02-24→ Common Stock (16,250 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the shares on January 7, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on April 7, 2020 and ending on January 7, 2023.